Anavasi Diagnostics, a company recently founded out of Professor Barry Lutz’s lab at the 爱豆社区,聽聽The funding will accelerate the launch and broad market availability of the molecular diagnostic platform for the detection of RNA indicative of the SARS-CoV-2 / COVID-19 virus.
The project was initiated less than a year ago and advanced quickly with coaching and support from the WE-REACH team and the NIH RADx initiative. Learn聽 more about the exciting journey this team has been on as they moved their technology from university-based research to a funded commercial enterprise.
